Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Gain (Loss) on Disposition of Assets

2.4 / 5 stars · 56/117 Roast Me

Lantheus Holdings, Inc. Gain (Loss) on Disposition of Assets

Lantheus Holdings, Inc. (LNTH) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Income Statement › Other Income

us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-02-26

  • Lantheus Holdings, Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • Lantheus Holdings, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $0.00.
  • Lantheus Holdings, Inc. gain (loss) on disposition of assets for the quarter ending 2025-06-30 was $0.00.
  • Lantheus Holdings, Inc. gain (loss) on disposition of assets for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
  • Lantheus Holdings, Inc. gain (loss) on disposition of assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • Lantheus Holdings, Inc. gain (loss) on disposition of assets for fiscal 2024 was $8.41M.
  • Lantheus Holdings, Inc. gain (loss) on disposition of assets for fiscal 2023 was $0.00.
  • Lantheus Holdings, Inc. gain (loss) on disposition of assets for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
Period endGain (Loss) on Disposition of Assets 3 monthGain (Loss) on Disposition of Assets 6 monthGain (Loss) on Disposition of Assets 9 monthGain (Loss) on Disposition of Assets 12 monthGain (Loss) on Disposition of Assets 12 month as first filed
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2025-11-06
$0.00
10-Q · filed 2025-11-06
$2.16M
derived: sum of 4 quarters · filed 2026-02-26
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$0.00
10-Q · filed 2025-08-06
$2.16M
derived: sum of 3 quarters · filed 2026-02-26
$2.16M
derived: sum of 4 quarters · filed 2026-02-26
2025-03-31$0.00
10-Q · filed 2025-05-07
$2.16M
derived: sum of 2 quarters · filed 2026-02-26
$2.16M
derived: sum of 3 quarters · filed 2026-02-26
$2.16M
derived: sum of 4 quarters · filed 2026-02-26
2024-12-31$2.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$2.16M
derived: sum of 2 quarters · filed 2026-02-26
$2.16M
derived: sum of 3 quarters · filed 2026-02-26
$8.41M
10-K · filed 2026-02-26
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2025-11-06
$6.25M
10-Q · filed 2025-11-06
-$45.53M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$6.25M
10-Q · filed 2025-08-06
-$45.53M
derived: sum of 3 quarters · filed 2026-02-26
$6.25M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$6.25M
10-Q · filed 2025-05-07
-$45.53M
derived: sum of 2 quarters · filed 2026-02-26
$6.25M
derived: sum of 3 quarters · filed 2026-02-26
$6.25M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$51.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
$51.79M
10-K · filed 2024-02-22
2023-09-30$51.79M
10-Q · filed 2024-11-06
$51.79M
derived: sum of 2 quarters · filed 2024-11-06
$51.79M
10-Q · filed 2024-11-06
$51.79M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
$0.00
10-Q · filed 2024-07-31
$0.00
derived: sum of 3 quarters · filed 2025-02-26
$0.00
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$0.00
10-Q · filed 2024-05-02
$0.00
derived: sum of 2 quarters · filed 2025-02-26
$0.00
derived: sum of 3 quarters · filed 2025-02-26
$0.00
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$0.00
derived: sum of 2 quarters · filed 2025-02-26
$0.00
derived: sum of 3 quarters · filed 2025-02-26
$0.00
10-K · filed 2025-02-26
2022-09-30$0.00
10-Q · filed 2023-11-02
$0.00
derived: sum of 2 quarters · filed 2023-11-02
$0.00
10-Q · filed 2023-11-02
$0.00
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$0.00
10-Q · filed 2022-08-04
$0.00
10-Q · filed 2022-08-04
$0.00
derived: sum of 3 quarters · filed 2024-02-22
$0.00
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$0.00
10-Q · filed 2022-04-29
$0.00
derived: sum of 2 quarters · filed 2024-02-22
$0.00
derived: sum of 3 quarters · filed 2024-02-22
$0.00
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$0.00
derived: sum of 2 quarters · filed 2024-02-22
$0.00
derived: sum of 3 quarters · filed 2024-02-22
$15.26M
10-K · filed 2024-02-22
2021-09-30$0.00
10-Q · filed 2022-11-03
$0.00
derived: sum of 2 quarters · filed 2022-11-03
$15.26M
10-Q · filed 2022-11-03
$13.46M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$0.00
10-Q · filed 2022-08-04
$15.26M
10-Q · filed 2022-08-04
$13.46M
derived: sum of 3 quarters · filed 2022-08-04
$13.46M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31$15.26M
10-Q · filed 2022-04-29
$13.46M
derived: sum of 2 quarters · filed 2022-04-29
$13.46M
derived: sum of 3 quarters · filed 2022-04-29
$13.46M
derived: sum of 4 quarters · filed 2022-04-29
2020-12-31-$1.80M
10-K · filed 2022-02-24
-$1.80M
derived: sum of 2 quarters · filed 2022-02-24
-$1.80M
derived: sum of 3 quarters · filed 2022-02-24
-$2.25M
10-K · filed 2023-02-23
2020-09-30$0.00
10-Q · filed 2021-11-04
$0.00
derived: sum of 2 quarters · filed 2021-11-04
$0.00
10-Q · filed 2021-11-04
2020-06-30$0.00
10-Q · filed 2021-07-28
$0.00
10-Q · filed 2021-07-28
2020-03-31$0.00
10-Q · filed 2021-05-04
2019-12-31-$286.00K
10-K · filed 2022-02-24
2018-12-31-$842.00K
10-K · filed 2021-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B